Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Set to Expand Saliently at a Robust CAGR during the Forecast

1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Set to Expand Saliently at a Robust CAGR during the Forecast Period 2018- 2026 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Drug Type , and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 Global Amyotrophic Lateral Sclerosis (ALS) Market Download PDF Brochure of Market Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1206 Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease and motor neuron disease (MND), is a neurodegenerative disease, afecting nerve cells in the brain and spinal cord that controls voluntary muscles. The disease is progressive in nature, meaning it gets worse over time. According to a study published in Centers for Disease Control and Prevention, in 2016, around 14,713 people were diagnosed with ALS in the U.S. and prevalence rate of ALS was 4.7 cases per 100,000 people in 2012. The prevalence rate increased to 5.0 cases per 100,000 people and around 15,908 people were diagnosed with ALS in 2013, according to the same study. The increasing prevalence of ALS is in turn, expected to support growth of the amyotrophic lateral sclerosis (ALS) treatment market in the near future.

2. Browse more about the Deep Brain Stimulation Devices Market Study: https://www.coherentmarketinsights.com/insight/request-customization/1206 Approval of novel innovative drugs is expected to boost growth in amyotrophic lateral sclerosis treatment market In May 2017, The U.S. Food and Drug Administration (FDA) approved Radicava (edaravone), an innovative drug used in the treatment of amyotrophic lateral sclerosis (ALS). This was the frst drug to be approved after over 20 years since the last FDA-approved drug for ALS. The approval of this drug would provide an additional option for patients sufering from this deadly disease. Increasing incidence of ALS is expected to increase the adoption rate of this drug, in turn, boosting market growth. The drug has already been approved in Japan and South Korea in 2015. Initiatives taken by some associations to increase awareness about diagnosis and treatment of ALS among population is also expected to drive market growth during forecast period (2017-2025). For instance in 2014, the ALS Ice Bucket Challenge, a social media–centered campaign, received extensive public visibility and created increased awareness of ALS. In 2015, a group of ALS organizations in the U.S., including the ALS Association, Les Turner ALS Foundation, and ALS Therapy Development Institute, re- introduced the Ice Bucket Challenge to raise further funds and spread awareness about ALS among population. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting frm ofering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights

3. 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com